25
May 2016
Share This
0 Comments

Dr. Duncan Stewart: "Be wary of any stem cell therapy that is fee-based and has not been validated through a complete clinical trial process."

Researcher/clinician Stewart to lead OIRM’s ‘next phase of growth’

Posted by

The Ontario Institute for Regenerative Medicine (OIRM) today named Dr. Duncan Stewart, one of Canada’s leading stem cell researchers, as its new President and Scientific Director.

“It will be my pleasure to serve OIRM by helping the organization, its researchers, trainees and staff to fulfill their passion to make a difference for all Ontarians,” Dr. Stewart said in a media release.

He succeeds Dr. Janet Rossant, who launched OIRM in 2014 but recently took on a new role as the Gairdner Foundation’s President and Scientific Director.  She praised Dr. Stewart “the perfect choice to lead OIRM as it moves into the next phase of growth.”

The head of research at The Ottawa Hospital and a professor at the University of Ottawa, Dr. Stewart co-leads an early stage clinical trial to test the use of stem cells to treat septic shock. It has shown promising preliminary results.  And he is conducting a Phase 2 trial to investigate the use of genetically enhanced stem cells to treat heart attack patients.

Dr. Stewart will remain in Ottawa to pursue his lab and clinical research activities and to carry on as Executive Vice-President of Research at The Ottawa Hospital.

“Given the breadth of his skills, Duncan brings unique perspectives on the regenerative medicine environment, particularly in the critical area of clinical trials and the development of new treatments, which is a key part of our mission,” said Sharon Colle, Chair of the OIRM Board and President and CEO, of The Foundation Fighting Blindness.

Leave a Reply

Your email address will not be published. Required fields are marked *

If you are a human, do not fill out this field